Internal jugular vein thrombosis by protein C activated resistance
- 30 November 2011
- journal article
- case report
- Published by Elsevier in European Annals of Otorhinolaryngology, Head and Neck Diseases
- Vol. 128 (5) , 269-271
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Factor V Leiden thrombophiliaGenetics in Medicine, 2011
- High Prevalence of Activated Protein C Resistance and Factor V Leiden Mutation in an Arab Population and Patients With Venous Thrombosis in KuwaitDiagnostic Molecular Pathology, 2010
- The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studiesHaematologica, 2007
- Malignancies, Prothrombotic Mutations, and the Risk of Venous ThrombosisJAMA, 2005
- Investigation and management of heritable thrombophiliaBritish Journal of Haematology, 2001
- Factor V Leiden paradox: risk of deepvein thrombosis but not of pulmonary embolismThe Lancet, 2000
- Fréquence de la résistance à la protéine C activée à TunisLa Revue de Médecine Interne, 1997
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences of the United States of America, 1993